FSPHX
Price
$30.12
Change
-$0.01 (-0.03%)
Updated
Nov 18 closing price
Net Assets
6.22B
RYCFX
Price
$51.75
Change
+$0.28 (+0.54%)
Updated
Nov 18 closing price
Net Assets
104.62M
Interact to see
Advertisement

FSPHX vs RYCFX

Header iconFSPHX vs RYCFX Comparison
Open Charts FSPHX vs RYCFXBanner chart's image
Fidelity Select Health Care
Price$30.12
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets6.22B
Rydex Biotechnology C
Price$51.75
Change+$0.28 (+0.54%)
VolumeN/A
Net Assets104.62M
FSPHX vs RYCFX Comparison Chart in %
View a ticker or compare two or three
VS
FSPHX vs. RYCFX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and RYCFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. RYCFX (105M). FSPHX pays higher dividends than RYCFX: FSPHX (0.02) vs RYCFX (0.00). FSPHX was incepted earlier than RYCFX: FSPHX (44 years) vs RYCFX (25 years). RYCFX (2.43) is less costly to investors than FSPHX (0.63). RYCFX is a more actively managed with annual turnover of: 79.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than RYCFX: FSPHX (0) vs RYCFX (2500). RYCFX annual gain was more profitable for investors over the last year : 3.00 vs. FSPHX (0.35). FSPHX return over 5 years is better than : -8.45 vs. RYCFX (-29.96).
FSPHXRYCFXFSPHX / RYCFX
Total Expense Ratio0.632.3826%
Annual Report Gross Expense Ratio0.632.4326%
Fund Existence44 years25 years-
Gain YTD10.56926.74240%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B105M5,920%
Annual Yield % from dividends0.020.00-
Returns for 1 year0.353.0012%
Returns for 3 years10.513.67287%
Returns for 5 years-8.45-29.9628%
Returns for 10 years39.39-31.40-125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMHX8.480.01
+0.12%
Invesco SteelPath MLP Alpha R5
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.44N/A
N/A
Bruce
REMVX11.11N/A
N/A
RBC Emerging Markets Value Equity I
CVTCX55.08-0.41
-0.74%
Calamos Growth & Income C